SCHEMBL440248

SCHEMBL440248

C=C(C(=O)O)C(C)[Si](C)(C)O[Si](C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
XBP1 P17861 1/20 0.31
ATM Q13315 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL440646 0.83
SCHEMBL445548 0.83
SCHEMBL15939120 0.75 LMNA (0.31) LMNAMAPTXBP1ATMSMN1; SMN2
SCHEMBL8467725 0.75
SCHEMBL1801550 0.72 CHRM1 (0.32)
SCHEMBL6364020 0.71
SCHEMBL23413739 0.70
SCHEMBL2915534 0.69 LMNA (0.46) LMNAMAPTXBP1ATMSMN1; SMN2
SCHEMBL15939421 0.69 LMNA (0.30) LMNAMAPTXBP1ATMSMN1; SMN2
SCHEMBL27496313 0.67 TP53 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9056880-B2 Process for producing hydrolysis-resistant silicone compounds JOHNSON & JOHNSON VISION CARE, INC. (US) 2015-06-16 US disclosed
US-8921449-B2 Hydrolysis-resistant silicone compounds JOHNSON & JOHNSON VISION CARE INC. (US) 2014-12-30 US disclosed
US-20140128564-A1 PROCESS FOR PRODUCING HYDROLYSIS-RESISTANT SILICONE COMPOUNDS FUJISAWA KAZUHIKO (JP) 2014-05-08 US disclosed
US-8637589-B2 Silicone prepolymer solutions JOHNSON & JOHNSON VISION CARE, INC. (US) 2014-01-28 US disclosed
EP-2388281-B1 SILICONE MONOMER NOF CORP (JP) 2013-11-06 EP disclosed
US-8569538-B2 Acryloyl materials for molded plastics JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-10-29 US disclosed
US-8481608-B2 Silicone monomer NOF CORPORATION (JP) 2013-07-09 US disclosed
US-20130131298-A1 HYDROLYSIS-RESISTANT SILICONE COMPOUNDS TORAY INDUSTRIES, INC. (JP) 2013-05-23 US disclosed
US-8399539-B2 Soluble silicone prepolymers JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-03-19 US disclosed
US-20120065348-A1 SOLUBLE SILICONE PREPOLYMERS TORAY INDUSTRIES, INC. (JP) 2012-03-15 US disclosed
US-8053539-B2 Prepared by purifying acrylic siloxanyl containing monomers by distillation in the presence of at least one polymerization inhibitor which can be an alkylhydroquinone or a hydroxynaphthalene; without substantial amounts of polymerization product(s) and without discoloration; contact lenses JOHNSON & JOHNSON VISION CARE INC. (US) 2011-11-08 US disclosed
US-8040078-B1 LED dimming circuit KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2011-10-18 US disclosed
US-20110077322-A1 Silicone Prepolymer Solutions TORAY INDUSTRIES, INC. (JP) 2011-03-31 US disclosed
US-7897654-B2 Silicone prepolymer solutions JOHNSON & JOHNSON VISION CARE INC. (US) 2011-03-01 US disclosed
US-20090171026-A1 SILICONE PREPOLYMER SOLUTIONS JOHNSON & JOHNSON VISION CARE, INC. 2009-07-02 US disclosed
US-20090005528-A1 SOLUBLE SILICONE PREPOLYMERS JOHNSON & JOHNSON VISION CARE, INC. 2009-01-01 US disclosed
US-20080081850-A1 Such as reaction of butyldimethylsilanol with 3-trichlorosilylpropyl methacrylate to produce 3-[tris(butyldimethylsiloxy)silyl]propyl methacrylate; steric hindrance, purity; copolymers with acrylate endcapped polysiloxane and acrylic monomers; contact and intraocular lenses, artificial cornea JOHNSON & JOHNSON VISION CARE, INC. 2008-04-03 US disclosed
US-7317117-B2 Siloxanyl-containing monomers JOHNSON & JOHNSON VISION CARE, INC. (US) 2008-01-08 US disclosed
US-20080004401-A1 SILOXANYL MATERIALS FOR MOLDED PLASTICS JOHNSON & JOHNSON VISION CARE, INC. 2008-01-03 US disclosed
US-20080004383-A1 ACRYLOYL MATERIALS FOR MOLDED PLASTICS TORAY INDUSTRIES, INC. (JP) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140128564-A1 PROCESS FOR PRODUCING HYDROLYSIS-RESISTANT SILICONE COMPOUNDS LSS, PIGS, STS LMNA 1576/4885MAPT 2702/4885XBP1 3993/4885
US-20090005528-A1 SOLUBLE SILICONE PREPOLYMERS NOS3, NOS2, PCNA LMNA 121/4885MAPT 4352/4885XBP1 3985/4885
US-20080004383-A1 ACRYLOYL MATERIALS FOR MOLDED PLASTICS ACR, HAAO, PORCN LMNA 261/4885MAPT 1596/4885XBP1 4066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.